Purgenlabs Acetaminophen

Description

Acetaminophen (APAP) is a non-opioid analgesic and antipyretic agent. It is commonly used for the relief of mild to moderate pain and the reduction of fever. The chemical formula for acetaminophen is C8H9NO2, and it has a molecular weight of 151.16 g/mol. Acetaminophen is typically available in various dosage forms, including tablets, capsules, and liquid formulations. The compound appears as a white, crystalline powder that is soluble in water and alcohol.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains. It is also indicated for the temporary reduction of fever.

There are no teratogenic effects associated with this drug, and no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children 12 years of age and older are advised to take 1 to 2 tablespoonfuls orally every 4 to 6 hours as needed. The maximum dosage should not exceed 6 tablespoonfuls within a 24-hour period.

Use of this medication is not recommended for children under 12 years of age.

Contraindications

Use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

• Known allergy to acetaminophen or any of the inactive ingredients in this product, as this may lead to severe allergic reactions.

• Exceeding the recommended dosage is contraindicated, as it may increase the risk of adverse effects.

Warnings and Precautions

This product contains acetaminophen, which poses significant risks if not used according to the guidelines. The maximum recommended daily dose is 6 tablespoonfuls within a 24-hour period. Severe liver damage may occur if the following conditions are met: exceeding 8 tablespoonfuls (4,000 mg of acetaminophen) in 24 hours, concomitant use with other medications containing acetaminophen, or consumption of three or more alcoholic beverages daily while using this product.

Allergy Alert Acetaminophen may lead to severe skin reactions. Symptoms indicative of such reactions include skin reddening, blisters, and rash. In the event of a skin reaction, it is imperative to discontinue use immediately and seek medical assistance.

General Precautions This product should not be used in conjunction with any other medications containing acetaminophen, whether prescription or over-the-counter. Healthcare professionals should advise patients to consult a doctor or pharmacist if there is uncertainty regarding the presence of acetaminophen in other medications. Additionally, patients with liver disease or those taking the anticoagulant warfarin should seek medical advice prior to using this product. It is crucial to adhere strictly to the recommended dosage to avoid adverse effects.

Monitoring and Follow-Up Patients should be instructed to discontinue use and consult a healthcare provider if any of the following occur: pain worsens or persists beyond 10 days, fever intensifies or lasts more than 3 days, new symptoms develop, or if there is any redness or swelling, as these may indicate a serious underlying condition.

In the absence of specific emergency medical instructions, healthcare professionals should ensure that patients are aware of the importance of seeking immediate medical attention for any severe or concerning symptoms.

Side Effects

Patients using this product should be aware of potential adverse reactions associated with its use, particularly those related to acetaminophen.

Severe liver damage may occur if patients exceed the recommended dosage of more than 8 tablespoonfuls (4,000 mg) of acetaminophen within a 24-hour period, use this product in conjunction with other medications containing acetaminophen, or consume three or more alcoholic drinks daily while using this product.

Additionally, there is an allergy alert associated with acetaminophen, as it may cause severe skin reactions. Symptoms of such reactions can include skin reddening, blisters, and rash. If any of these symptoms occur, patients are advised to discontinue use immediately and seek medical assistance.

Patients should also be vigilant for other signs that may indicate a serious condition. They are advised to stop use and consult a healthcare professional if pain worsens or persists for more than 10 days, if fever intensifies or lasts longer than 3 days, if new symptoms arise, or if redness or swelling is observed. These symptoms could signify a more serious underlying issue that requires medical evaluation.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking warfarin, a blood-thinning agent. The combination may increase the risk of bleeding due to potential pharmacodynamic interactions.

Additionally, this medication should not be used in conjunction with any other products containing acetaminophen, whether prescription or over-the-counter. Patients are advised to verify the presence of acetaminophen in other medications by consulting a healthcare provider or pharmacist to avoid unintentional overdose and associated adverse effects.

Packaging & NDC

Below are the non-prescription pack sizes of Purgenlabs Acetaminophen (actaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this medication. For adolescents aged 12 years and older, the recommended dosage is 1 to 2 tablespoonfuls every 4 to 6 hours as needed, with a maximum of 6 tablespoonfuls in a 24-hour period. It is important to keep this medication out of reach of children to prevent accidental ingestion.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when treating patients with renal impairment, as specific guidelines or recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment should be closely monitored when using this product, which contains acetaminophen. The maximum daily dose for patients is limited to 6 tablespoonfuls within a 24-hour period.

It is critical to note that severe liver damage may occur if patients exceed 8 tablespoonfuls (4,000 mg of acetaminophen) in a 24-hour period, take this product concurrently with other medications containing acetaminophen, or consume 3 or more alcoholic drinks daily while using this product.

Due to the potential for increased risk of liver toxicity, patients with compromised liver function should be advised to adhere strictly to the recommended dosage and to avoid the aforementioned risk factors. Regular monitoring of liver function may be warranted in these patients to ensure safety and prevent adverse effects.

Overdosage

In the event of overdosage, it is critical to recognize the potential for severe liver damage associated with excessive intake of this product. The maximum recommended daily dose is 6 tablespoonfuls within a 24-hour period.

Risk Factors for Severe Liver Damage

Severe liver damage may occur under the following circumstances:

• Ingestion of more than 8 tablespoonfuls (equivalent to 4,000 mg of acetaminophen) within a 24-hour timeframe.

• Concurrent use of other medications that contain acetaminophen.

• Consumption of three or more alcoholic beverages daily while using this product.

Recommended Actions

Healthcare professionals should be vigilant in assessing patients who may have exceeded the recommended dosage or who present with symptoms indicative of liver impairment. Immediate medical evaluation is advised for any patient suspected of acetaminophen overdosage.

Management may include monitoring liver function tests and considering the administration of N-acetylcysteine as an antidote, particularly if the overdose is identified within a critical time frame. It is essential to provide supportive care and to educate patients on the importance of adhering to dosing guidelines to prevent such occurrences.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. Patients should be informed not to use this product in conjunction with any other medications that contain acetaminophen, whether prescription or nonprescription. If patients are uncertain about the presence of acetaminophen in their other medications, they should be encouraged to consult with a doctor or pharmacist.

It is essential to inform patients that they should not use this product if they have a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation. Additionally, patients should be advised to seek medical advice before using this product if they have liver disease or are currently taking the blood-thinning medication warfarin.

Patients must be cautioned to adhere strictly to the recommended dosage and not to exceed it. They should be instructed to discontinue use and consult a doctor if their pain worsens or persists for more than 10 days, if their fever intensifies or lasts longer than 3 days, or if they experience any new symptoms. Furthermore, patients should be advised to stop using the product and seek medical attention if they notice any redness or swelling, as these may indicate a serious condition.

Storage and Handling

The product is supplied in a container that must be stored at a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F). It is essential to protect the product from light to maintain its integrity. The bottle should be kept tightly closed when not in use to prevent contamination and degradation. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Purgenlabs Acetaminophen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)